Logo image of RNAC

CARTESIAN THERAPEUTICS INC (RNAC) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:RNAC - US8162123025 - Common Stock

6.88 USD
-0.02 (-0.29%)
Last: 12/5/2025, 8:00:01 PM
6.88 USD
0 (0%)
After Hours: 12/5/2025, 8:00:01 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
RNAC revenue by date.RNAC revenue by date.
110.777M
30.21%
26.004M
-76.53%
38.913M
49.64%
2.021M
-94.81%
686.021K
-66.06%
945.54K
37.83%
24.584M
2,500.00%
92.291M
275.41%
205.29M
122.44%
460.58M
124.36%
716.27M
55.51%
EBITDA
YoY % growth
RNAC ebitda by date.RNAC ebitda by date.
15.825M
573.09%
-84.873M
-636.32%
-35.167M
58.57%
N/AN/A-169.32M-184.62M
-9.04%
-96.9M
47.51%
-34.68M
64.21%
35.7M
202.94%
N/A
EBIT
YoY % growth
RNAC ebit by date.RNAC ebit by date.
14.538M
416.25%
-85.716M
-689.60%
-36.318M
57.63%
-89.907M
-147.55%
-107.317M
-19.36%
-137.16M
-27.81%
-146.046M
-6.48%
-121.617M
16.73%
-52.895M
56.51%
87.21M
264.87%
206.04M
136.26%
Operating Margin
RNAC operating margin by date.RNAC operating margin by date.
13.12%-329.63%-93.33%-4,448.64%-15,643.39%-14,506.04%-594.07%-131.78%-25.77%18.93%28.77%
EPS
YoY % growth
RNAC eps by date.RNAC eps by date.
8.40
190.32%
-10.20
-221.43%
-11.68
-14.51%
-2.39
79.52%
-3.44
-43.74%
-3.68
-6.89%
-2.73
25.63%
-2.81
-2.61%
-2.63
6.18%
2.60
198.84%
N/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-0.87
-47.53%
-0.87
-28.00%
-0.86
-271.02%
-0.87
36.93%
-0.96
-9.76%
-0.50
42.34%
-0.53
37.97%
-0.56
35.55%
-0.59
37.86%
Revenue
Q2Q % growth
96.563K
25.41%
143.208K
-86.98%
143.208K
-51.94%
143.208K
-68.32%
51K
-47.18%
303.96K
112.25%
303.96K
112.25%
303.96K
112.25%
303.96K
496.00%
EBITDA
Q2Q % growth
N/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-24M
-25.31%
-25.561M
-16.78%
-26.438M
-21.22%
-27.367M
-29.91%
-31.355M
-30.65%
N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-1.38
-22.12%
-0.86-0.52-60.11%
Q2 2025
Q2Q % growth
0.50
-7.41%
-0.831.33160.52%
Q1 2025
Q2Q % growth
-0.68
93.52%
-0.720.045.53%
Q4 2024
Q2Q % growth
-0.59
71.90%
-0.820.2327.70%
Q3 2024
Q2Q % growth
-1.13
37.22%
-0.93-0.20-21.74%
Q2 2024
Q2Q % growth
0.54
125.71%
-1.151.69146.91%
Q1 2024
Q2Q % growth
-10.50
-150.00%
-0.90-9.60-1,063.18%
Q4 2023
Q2Q % growth
-2.10
-275.00%
-1.07-1.03-96.08%
Q3 2023
Q2Q % growth
-1.80
-20.00%
-1.78-0.02-0.85%
Q2 2023
Q2Q % growth
-2.10
-216.67%
-2.450.3514.22%
Q1 2023
Q2Q % growth
-4.20
-160.87%
-2.67-1.53-57.51%
Q4 2022
Q2Q % growth
1.20
33.33%
-2.233.43153.82%
Q3 2022
Q2Q % growth
-1.50
68.75%
-0.17-1.33-758.49%
Q2 2022
Q2Q % growth
1.80
50.00%
-2.364.16176.26%
Q1 2022
Q2Q % growth
6.90
204.55%
-3.3110.21308.15%
Q4 2021
Q2Q % growth
0.90
121.43%
-2.233.13140.37%
Q3 2021
Q2Q % growth
-4.80
-77.78%
-2.27-2.53-111.15%
Q2 2021
Q2Q % growth
1.20
116.00%
-3.584.78133.48%
Q1 2021
Q2Q % growth
-6.60
-4.76%
-3.73-2.87-76.79%
Q4 2020
Q2Q % growth
-4.20
53.33%
-3.54-0.66-18.62%
Q3 2020
Q2Q % growth
-2.70
65.38%
1.84-4.54-247.06%
Q2 2020
Q2Q % growth
-7.50
32.43%
-0.23-7.27-3,167.97%
Q1 2020
Q2Q % growth
-6.30
32.26%
-8.562.2626.40%
Q4 2019
Q2Q % growth
-9.00 -6.43-2.57-40.06%
Q3 2019
Q2Q % growth
-7.80 -10.162.3623.22%
Q2 2019
Q2Q % growth
-11.10 -9.24-1.86-20.11%
Q1 2019
Q2Q % growth
-9.30 -10.831.5314.15%
RNAC Yearly EPS VS EstimatesRNAC Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 -20 -40 -60 -80 -100
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
452K
16.80%
248.37K203.63K81.99%
Q2 2025
Q2Q % growth
298K
-99.11%
828.75K-530.75K-64.04%
Q1 2025
Q2Q % growth
1.1M
-81.16%
801.424K298.576K37.26%
Q4 2024
Q2Q % growth
77K
-99.07%
105.825K-28.825K-27.24%
Q3 2024
Q2Q % growth
387K
-94.09%
2.331M-1.944M-83.40%
Q2 2024
Q2Q % growth
33.445M
537.17%
2.521M30.924M1,226.66%
Q1 2024
Q2Q % growth
5.84M
-1.65%
1.275M4.565M358.04%
Q4 2023
Q2Q % growth
8.266M
-50.78%
5.993M2.273M37.93%
Q3 2023
Q2Q % growth
6.551M
-68.37%
12.837M-6.286M-48.97%
Q2 2023
Q2Q % growth
5.249M
-86.63%
11.314M-6.065M-53.61%
Q1 2023
Q2Q % growth
5.938M
-82.53%
12.07M-6.132M-50.80%
Q4 2022
Q2Q % growth
16.795M
-43.90%
11.918M4.877M40.92%
Q3 2022
Q2Q % growth
20.71M
-15.22%
25.719M-5.009M-19.48%
Q2 2022
Q2Q % growth
39.273M
99.73%
14.057M25.216M179.38%
Q1 2022
Q2Q % growth
33.999M
207.68%
13.378M20.621M154.14%
Q4 2021
Q2Q % growth
29.937M
150.50%
17.936M12.001M66.91%
Q3 2021
Q2Q % growth
24.427M
425.76%
12.431M11.996M96.50%
Q2 2021
Q2Q % growth
19.663M 7.273M12.39M170.36%
Q1 2021
Q2Q % growth
11.05M 7.672M3.378M44.03%
Q4 2020
Q2Q % growth
11.951M
79.61%
5.571M6.38M114.52%
Q3 2020
Q2Q % growth
4.646M 21.356M-16.71M-78.24%
Q2 2020
Q2Q % growth

-100.00%
19.125M-19.125M-100.00%
Q1 2020
Q2Q % growth

-100.00%
%
Q4 2019
Q2Q % growth
6.654M 2.917K6.651M227,995.43%
Q3 2019
Q2Q % growth
2.652K-2.652K-100.00%
Q2 2019
Q2Q % growth
13K 2.04K10.96K537.25%
RNAC Yearly Revenue VS EstimatesRNAC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 200M 400M 600M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS20.78% 18.02% -16.95% -9.95%
Revenue-76.35% -75.15% 6.2% 6.2%